Colorcon to incorporate TruTag's edible 'optical barcodes' in tablet film coatings

6 Aug 2019

The benefits of this innovation include the ability to instantly and unequivocally authenticate products when suspect events.

Colorcon and TruTag Technologies have announced the execution of a development agreement to enable on-dose verification technology for tablets by combining TruTag’s silica-based microtag authentication technology with Colorcon’s expertise in film coating systems, modified release technologies and specialty excipients.

Colorcon to incorporate TruTag's edible 'optical barcodes' in tablet film coatings

The collaboration will see TruTag’s edible “optical barcodes” incorporated into existing Colorcon coatings, with the microtags verified by either a smart phone application or a proprietary reader. Each SiO2 particle is encoded with an optical signature that is manufactured into the microtags without the use of additional additives or markers.

The benefits of this innovation include the ability to instantly and unequivocally authenticate products when suspect events occur and specifically addresses the problems of counterfeiting, product diversion, returns monitoring, quality control and product recalls in pharmaceuticals and nutraceuticals.

“On-dose authentication technology represents the next generation in pharmaceutical supply-chain security by providing a powerful tool for tracking product from plant to patient,” said Kelly Boyer, General Manager, Film Coatings of Colorcon. “By seamlessly enabling authentication, these digitized coatings confirm the quality and origin of medicines thereby safeguarding both patients and brands. Colorcon continues to advance technologies and services to meet industry challenges with innovative solutions.”

“Colorcon brings a shared vision for bringing innovation to the pharmaceutical industry, said Michael Bartholomeusz, CEO of TruTag Technologies. “They are market leaders in the film-coating space, and they have the caliber and reach to make intelligent coatings a new industry standard. We are thrilled to be working with them.”

Read More

Related news

EC approves its first plant-derived cannabis-based medicine

EC approves its first plant-derived cannabis-based medicine

24 Sep 2019

Epidyolex (cannabidiol) approved for the treatment of seizures in patients with two rare, severe forms of childhood-onset epilepsy.

Read more 
Integrating glucose sensing and insulin delivery technologies

Integrating glucose sensing and insulin delivery technologies

18 Sep 2019

Collaboration aims to provide a connected device experience for millions of people living with diabetes using insulin.

Read more 
Drivers behind Saudi Arabia’s forecast 10.74 $billion 2022 market

Drivers behind Saudi Arabia’s forecast 10.74 $billion 2022 market

9 Sep 2019

Growing population, increase in non-communicable diseases and major investment in new hospitals, clinics and treatments driving growth.

Read more 
China relaxes import regulations to improve access and availability of affordable medicines

China relaxes import regulations to improve access and availability of affordable medicines

3 Sep 2019

The potential for generics to support the healthcare needs of China is significant.

Read more 
Exciting new vaccine targets killer disease TB

Exciting new vaccine targets killer disease TB

28 Aug 2019

Australian researchers produce early-stage vaccine which is inhaled into the lungs.

Read more 
Switzerland overtakes Germany as Europe’s biggest drug delivery innovator

Switzerland overtakes Germany as Europe’s biggest drug delivery innovator

16 Aug 2019

Pipeline of new drugs has helped drive increased innovation in packaging and drug delivery devices.

Read more 
How real-world data can revolutionise drug development

How real-world data can revolutionise drug development

9 Aug 2019

Utilising the current data environment and its data pools for the benefit of advancing research.

Read more 
Mylan and Pfizer create new global pharma company

Mylan and Pfizer create new global pharma company

29 Jul 2019

The transaction will allow the new company to expand the geographic reach of Mylan's existing broad product portfolio and future pipeline.

Read more 
GSK opens new continuous manufacturing facilities in Singapore

GSK opens new continuous manufacturing facilities in Singapore

11 Jul 2019

Opening of continuous manufacturing facilities and expansion of production building will boost capabilities to accelerate the supply of new breakthrough medicines to patients globally.

Read more 
Catalent extends global commercial spray drying capabilities in Europe

Catalent extends global commercial spray drying capabilities in Europe

9 Jul 2019

Company's customers to have immediate access to Niro PSD2 and PSD4 spray driers, which are supported by dedicated clean area facilities for both solvent and aqueous processing of potent or non-potent drug formulations.

Read more